Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Management of Insomnia01:19

Management of Insomnia

207
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
207
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

119
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
119
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

225
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
225
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

150
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
150
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

170
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
170
Drug Dependence01:17

Drug Dependence

950
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
950

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Identifying major life events associated with insomnia disorder: Stressors that disrupt safety, stability, and identity.

Sleep health·2026
Same author

Discrepancies Between Subjective and Objective Evaluation of Sleep: Potential Marker for Mild Cognitive Impairment.

Sleep medicine research·2026
Same author

Solubility, speciation and thermodynamics of Fe in reducing aqueous KCl solutions.

RSC advances·2025
Same author

Once-Nightly Sodium Oxybate Meets American Academy of Sleep Medicine Criteria for Treatment of Narcolepsy.

Journal of sleep research·2025
Same author

A randomized controlled trial of telemedicine CBTI and PUMAS for prenatal insomnia: Reducing nocturnal cognitive arousal is a treatment mechanism for alleviating insomnia and depression during pregnancy.

Sleep medicine·2025
Same author

Prevention of Pain Interference in Insomnia Patients via Digital Cognitive-Behavioral Therapy for Insomnia.

Behavioral sleep medicine·2025

相关实验视频

Updated: May 12, 2025

Chronic Sleep Deprivation in Mouse Pups by Means of Gentle Handling
03:46

Chronic Sleep Deprivation in Mouse Pups by Means of Gentle Handling

Published on: October 11, 2018

9.9K

一个机制研究,评估停止慢性催眠使用的困难.

Timothy Roehrs1,2, Gail Koshorek3, Mohammad Sibai3

  • 1Henry Ford Health System, Sleep Disorders and Research Center & Research Ctr Henry Ford Hospital, 2799 West Grand Blvd, CPF-3 Detroit, MI, 48202, USA. troehrs1@hfhs.org.

Psychopharmacology
|May 9, 2025
PubMed
概括
此摘要是机器生成的。

慢性催眠使用可能很难停止,特别是对于那些过度兴奋的人来说. 像埃斯托皮克隆这样的受体非特异性催眠药可能比索尔皮德姆XR这样的特异性催眠药提出更大的中止挑战.

关键词:
慢性失眠症是什么 慢性失眠症停止使用催眠药物.埃斯索皮克隆是一种埃斯索皮克隆索尔皮XR是一种XR药物.

更多相关视频

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
06:23

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

Published on: September 22, 2020

5.2K
Establishing a Device for Sleep Deprivation in Mice
05:05

Establishing a Device for Sleep Deprivation in Mice

Published on: September 22, 2023

1.3K

相关实验视频

Last Updated: May 12, 2025

Chronic Sleep Deprivation in Mouse Pups by Means of Gentle Handling
03:46

Chronic Sleep Deprivation in Mouse Pups by Means of Gentle Handling

Published on: October 11, 2018

9.9K
A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
06:23

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

Published on: September 22, 2020

5.2K
Establishing a Device for Sleep Deprivation in Mice
05:05

Establishing a Device for Sleep Deprivation in Mice

Published on: September 22, 2023

1.3K

科学领域:

  • 睡眠医学 睡眠医学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 由于潜在的滥用责任,慢性催眠使用是一个临床问题.
  • 失眠和过度兴奋是影响催眠停药困难的关键因素.

研究的目的:

  • 为了比较慢性催眠药在失眠患者中停药的难度,有或没有过度兴奋.
  • 评估受体非特异性催眠药 (埃索皮克隆) 是否比受体特异性催眠药 (zolpidem XR) 构成更大的停药挑战.

主要方法:

  • 41名没有其他睡眠障碍或并发症的成年失眠患者 (23-61岁) 被随机分配给6个月的佐洛皮德姆XR,埃索皮克隆或安慰剂.
  • 晚上使用后,参与者接受了为期2周的停药期,并可以选择自行服用他们分配的失明药物.
  • 用于查的是夜间多睡眠图 (NPSG).

主要成果:

  • 51%的参与者成功地停止了催眠药,继续使用的人平均服用了3个囊.
  • 与没有过度兴奋的患者相比,失眠患者在停止使用催眠药时遇到更大的困难.
  • 停止服用埃斯托皮克隆的患者与停止服用佐洛皮XR或安慰剂的患者相比,出现了更大的困难.

结论:

  • 大多数参与者成功地停止了慢性催眠使用.
  • 停药困难与过度兴奋和使用的催眠类型 (埃索皮克隆与佐尔皮德姆XR) 有关.
  • 在那些继续使用的人中,在两周的停用期间,消费量下降.